摘要
犬尿喹啉酸(kynurenic acid,KYNA)是色氨酸(Trp)的代谢产物之一,广泛分布于哺乳动物的体液和中枢神经系统中,能拮抗兴奋性氨基酸(EAA)和烟碱受体,与某些神经系统、眼科、肾脏、免疫性等疾病都有关联。本文就KYNA的生化特性与相关疾病关系作一简单综述。
出处
《实用预防医学》
CAS
2006年第4期1092-1094,共3页
Practical Preventive Medicine
参考文献21
-
1Schwarcz R,Pellicciari R.Manipulation of Brain Kynurenines:Glial Targets,Neuronal Effects,and Clinical Opportunities[J].J Pharmacol Exp Ther,2002,303(1):1-10.
-
2Stone TW.Inhibitors of kynurenine pathway[J].Eur J Med Chem,2000,35(2):179-186.
-
3Dazzi C,Candiano G,Massazza S,et al.New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids[J].J Chromatogr B biomed Sci Appl,2001,751 (1):61 -68.
-
4Zsizsik BK,Hardeland R.Formation of kynurenic and xanthurenic acids from kynurenine and3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum:role of a novel,oxidative pathway[J].Comp Biochem Physiol C Toxicol Pharmacol,2002,133 (3):383-392.
-
5Nemeth H,Robotka H,Kis Z,et al.Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures.An electrophysiological and behavioural study[J].Neuropharmacology,2004,47(6):916-925.
-
6Hilmas C,Pereira EFR,Alkondon M,et al.The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non -α7 nicotinic receptor expression:physiopathological implications[J].J Neueosicence,2001,21(19):7463-7473.
-
7Robotka H,Nemeth H,Somlai C,et al.Systemically administered glucosamine-kynurenic acid,but not pure kynurenic acid,is effective in decreasing the evoked activity in area CA1 of the rat hippocampus[J].Eur J Pharmacol,2005,513(1-2):75-80.
-
8Kepplinger B,Baran H,Kainz A,et al.Age-related increase of kynurenic acid in human cerebrospinal fluid-IgG and beta2-microglobulin changes[J].Neurosignals,2005,14(3):126-135.
-
9Ceresoli-Borroni G,Schwarcz R.Neonatal Asphyxia in Rats:Acute Effects on Cerebral Kynurenine Metabolism[J].Pediatr Res,2001,50(2):231-235.
-
10Nilsson LK,Linderholm KR,Engberg G,et al.Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia[J].Schizophr Res,2005,[Epub ahead of print]
二级参考文献10
-
1[1]Jutta Urenjak,Tihomir P Obrenovitch. Kynurenine 3-Hydroxylase Inhibition in Rats: Effects on Extracellular Kynurenic Acid Concentratin and N-Methyl-D-Aspartate-Induced Deplarisation in the Striatum[J]. J Neurochem, 2000, 75(6): 2427-2433.
-
2[2]Blandini F, Porter RHP, Greenamyre JT.Glutamate and Parkinson's disease[J]. Mol Neurobiol,1996,12:73-99.
-
3[3]H Baran, Hainfeller JA, Kepplinger B, et al.Kynurenic acid metabolism in the brain of HIV-1 infected patients[J]. J Neural Transm, 2000,107:1127-1138.
-
4[4]Klockgether T, Turski L. ()Toward an understandanding of the role glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia[J]. Ann Neurol, 1993,34:585-593.
-
5[5]Bernard V, Gardiol A, Faucheux B, et al. Expression of glutamate receptors in the human and rat basal ganglia:effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion[J]. J Comp Neurol,1996,368:553-568.
-
6[6]Limousin P, Pollak P, Benazzouz A,et al.Effect of parkinsonian signs and syptoms of bilateral subthalamic nucleus stimulation[J]. Lancet,1995, 345: 91-95.
-
7[7]Miranda AF, Boegman RJ,Beninger RJ. Protection against quinolinic acid mediated excitotoxicity in nigostriatal dopaminergic neurons by endogenous kynurenic acid[J]. Neuroscience,1997,78:967-975.
-
8[8]Rodriez MC, Obeso JA. Suthalamic nucleus-mediated excitotoxicity in Parkinson′s disease: A target for neuroprotectio[J]. Annals Neurology,1998, 44(Suppl 1):s175-s188.
-
9[9]Merino M, Vizuete ML, Cano J. The Non-NMDA Glutamate Receptor Antagonists, but Not NMDA Antagonists, Block the Intrastraital Neurotoxic Effect of MPP+[J].J Neurochem, 1999,73(2): 751-757.
-
10[10]Piallat B, Benazzou A, Benabid AL. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. J Neural transm Suppl, 1999, 55: 71-77.
-
1董存岩,皮兰敢,唐爱国,罗昔波,敖翔.108例健康成人血清犬尿喹啉酸含量测定[J].中国现代医学杂志,2008,18(7):920-921. 被引量:2
-
2皮兰敢,唐爱国,莫喜明,罗昔波,敖翔.高效液相色谱-荧光法测定血清犬尿喹啉酸和色氨酸方法的建立[J].中华检验医学杂志,2007,30(10):1134-1137. 被引量:4
-
3潘月瑢.儿童抗N-甲基-D-天冬氨酸受体脑炎的临床护理[J].安徽卫生职业技术学院学报,2016,15(3):76-77.
-
4项忠元,唐爱国,任亚萍,周前选.高效液相色谱-荧光法测定SLE患者血清色氨酸及其代谢产物[J].临床检验杂志,2010,28(1):9-12. 被引量:5
-
5徐冰馨,詹一鸣,高平进,朱鼎良,赵建幸.原发性高血压患者血浆色氨酸、犬尿氨酸和犬尿喹啉酸浓度的变化[J].检验医学,2012,27(8):624-627. 被引量:1
-
6侯振江,李进春.过氧化氢酶检测及其临床应用进展[J].医学检验进修杂志,2000,7(4):16-17.
-
7赵树铭,李祝全.糖化血红蛋白A1C的测定与临床意义[J].中国检验医学与临床,2000,1(2):75-76. 被引量:14
-
8王仁顺,莫克俭,谢衡生,周乐友.前列腺特异性抗原并非特异[J].中华泌尿外科杂志,1999,20(5):313-314. 被引量:9
-
9赵建幸,罗雪美,詹一鸣,陈波,朱鼎良.高效液相色谱——紫外、荧光双检测器同时测定人尿中犬尿氨酸和犬尿喹啉酸[J].检验医学,2009,24(9):659-662. 被引量:1
-
10朱光尊.抗N-甲基-D-天冬氨酸受体脑炎病人的护理体会[J].世界最新医学信息文摘,2016,0(50):246-246.